Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
37421 | 59 | 45.9 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
441 | 3 | TRAIL//SURVIVIN//APOPTOSIS | 26474 |
306 | 2 | TRAIL//SURVIVIN//APOPTOSIS | 18497 |
37421 | 1 | BCL2L12//BCL2L12A//BRAIN TUMOR GENET MED | 59 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BCL2L12 | authKW | 11790527 | 46% | 84% | 27 |
2 | BCL2L12A | authKW | 1035109 | 3% | 100% | 2 |
3 | BRAIN TUMOR GENET MED | address | 1035109 | 3% | 100% | 2 |
4 | CAKI 1 RENAL CANCER CELL LINE | authKW | 1035109 | 3% | 100% | 2 |
5 | G P ANICOLAOU ONCOL | address | 642472 | 10% | 21% | 6 |
6 | ACUTE POMYELOCYTIC LEUKEMIA | authKW | 517554 | 2% | 100% | 1 |
7 | AGS GASTRIC ADENOCARCINOMA CELL LINE | authKW | 517554 | 2% | 100% | 1 |
8 | BCL 2 FAMILY APOPTOTIC GENES | authKW | 517554 | 2% | 100% | 1 |
9 | BCL2 BCL 2 FAMILY | authKW | 517554 | 2% | 100% | 1 |
10 | BCL2L12 CELL LINES | authKW | 517554 | 2% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 269 | 36% | 0% | 21 |
2 | Cell Biology | 154 | 27% | 0% | 16 |
3 | Developmental Biology | 61 | 7% | 0% | 4 |
4 | Biochemistry & Molecular Biology | 42 | 25% | 0% | 15 |
5 | Medical Laboratory Technology | 21 | 3% | 0% | 2 |
6 | Genetics & Heredity | 17 | 8% | 0% | 5 |
7 | Biophysics | 15 | 7% | 0% | 4 |
8 | Medicine, Research & Experimental | 14 | 7% | 0% | 4 |
9 | Chemistry, Medicinal | 13 | 5% | 0% | 3 |
10 | Hematology | 12 | 5% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRAIN TUMOR GENET MED | 1035109 | 3% | 100% | 2 |
2 | G P ANICOLAOU ONCOL | 642472 | 10% | 21% | 6 |
3 | BELFER PL CANC SCI MED ONCOL MED | 517554 | 2% | 100% | 1 |
4 | BREAST CLIN ST SAVVAS | 517554 | 2% | 100% | 1 |
5 | CHEN XING HAI HOSITAL | 517554 | 2% | 100% | 1 |
6 | HLTH SCIBIOMED SCI PROGRAM | 517554 | 2% | 100% | 1 |
7 | SPA KYRIAKOU CHILDRENS HOSP | 517554 | 2% | 100% | 1 |
8 | THROAT CLIN | 517554 | 2% | 100% | 1 |
9 | CANC GENET PROD RECOMBINANT PROT | 258776 | 2% | 50% | 1 |
10 | EAR CLIN 1 | 258776 | 2% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOLOGICAL CHEMISTRY | 5829 | 10% | 0% | 6 |
2 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 942 | 5% | 0% | 3 |
3 | TUMOR BIOLOGY | 755 | 5% | 0% | 3 |
4 | GENES & DEVELOPMENT | 623 | 5% | 0% | 3 |
5 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | 484 | 2% | 0% | 1 |
6 | PHARMACEUTICAL CHEMISTRY JOURNAL | 465 | 2% | 0% | 1 |
7 | CLINICAL BIOCHEMISTRY | 402 | 3% | 0% | 2 |
8 | MOLECULAR MEDICINE | 333 | 2% | 0% | 1 |
9 | CHEMICAL BIOLOGY & DRUG DESIGN | 312 | 2% | 0% | 1 |
10 | PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES | 301 | 2% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BCL2L12 | 11790527 | 46% | 84% | 27 | Search BCL2L12 | Search BCL2L12 |
2 | BCL2L12A | 1035109 | 3% | 100% | 2 | Search BCL2L12A | Search BCL2L12A |
3 | CAKI 1 RENAL CANCER CELL LINE | 1035109 | 3% | 100% | 2 | Search CAKI+1+RENAL+CANCER+CELL+LINE | Search CAKI+1+RENAL+CANCER+CELL+LINE |
4 | ACUTE POMYELOCYTIC LEUKEMIA | 517554 | 2% | 100% | 1 | Search ACUTE+POMYELOCYTIC+LEUKEMIA | Search ACUTE+POMYELOCYTIC+LEUKEMIA |
5 | AGS GASTRIC ADENOCARCINOMA CELL LINE | 517554 | 2% | 100% | 1 | Search AGS+GASTRIC+ADENOCARCINOMA+CELL+LINE | Search AGS+GASTRIC+ADENOCARCINOMA+CELL+LINE |
6 | BCL 2 FAMILY APOPTOTIC GENES | 517554 | 2% | 100% | 1 | Search BCL+2+FAMILY+APOPTOTIC+GENES | Search BCL+2+FAMILY+APOPTOTIC+GENES |
7 | BCL2 BCL 2 FAMILY | 517554 | 2% | 100% | 1 | Search BCL2+BCL+2+FAMILY | Search BCL2+BCL+2+FAMILY |
8 | BCL2L12 CELL LINES | 517554 | 2% | 100% | 1 | Search BCL2L12+CELL+LINES | Search BCL2L12+CELL+LINES |
9 | BLADDER CANCER RELAPSE | 517554 | 2% | 100% | 1 | Search BLADDER+CANCER+RELAPSE | Search BLADDER+CANCER+RELAPSE |
10 | HIGH GRADE TAT1 BLADDER TUMORS | 517554 | 2% | 100% | 1 | Search HIGH+GRADE+TAT1+BLADDER+TUMORS | Search HIGH+GRADE+TAT1+BLADDER+TUMORS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TAGHAVI, MS , AKBARZADEH, A , MAHDIAN, R , AZADMANESH, K , JAVADI, G , (2013) CISPLATIN DOWNREGULATES BCL2L12, A NOVEL APOPTOSIS-RELATED GENE, IN GLIOBLASTOMA CELLS.IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL. VOL. 49. ISSUE 6. P. 465-472 | 21 | 49% | 2 |
2 | KORBAKIS, D , SCORILAS, A , (2012) QUANTITATIVE EXPRESSION ANALYSIS OF THE APOPTOSIS-RELATED GENES BCL2, BAX AND BCL2L12 IN GASTRIC ADENOCARCINOMA CELLS FOLLOWING TREATMENT WITH THE ANTICANCER DRUGS CISPLATIN, ETOPOSIDE AND TAXOL.TUMOR BIOLOGY. VOL. 33. ISSUE 3. P. 865-875 | 24 | 37% | 14 |
3 | KONTOS, CK , SCORILAS, A , (2012) MOLECULAR CLONING OF NOVEL ALTERNATIVELY SPLICED VARIANTS OF BCL2L12, A NEW MEMBER OF THE BCL2 GENE FAMILY, AND THEIR EXPRESSION ANALYSIS IN CANCER CELLS.GENE. VOL. 505. ISSUE 1. P. 153-166 | 27 | 31% | 4 |
4 | CHIEN, ST , YANG, TF , YANG, MC , HSU, CM , HONG, YR , LEE, TM , (2015) DIFFERENTIAL ROLES OF BCL2L12 AND ITS SHORT VARIANT IN BREAST CANCER LYMPH NODE METASTASIS.ONCOLOGY REPORTS. VOL. 34. ISSUE 2. P. 961 -971 | 13 | 62% | 0 |
5 | ADAMOPOULOS, PG , KONTOS, CK , TSIAKANIKAS, P , SCORILAS, A , (2016) IDENTIFICATION OF NOVEL ALTERNATIVE SPLICE VARIANTS OF THE BCL2L12 GENE IN HUMAN CANCER CELLS USING NEXT-GENERATION SEQUENCING METHODOLOGY.CANCER LETTERS. VOL. 373. ISSUE 1. P. 119 -129 | 20 | 33% | 1 |
6 | FENDRI, A , KONTOS, CK , KHABIR, A , MOKDAD-GARGOURI, R , SCORILAS, A , (2011) BCL2L12 IS A NOVEL BIOMARKER FOR THE PREDICTION OF SHORT-TERM RELAPSE IN NASOPHARYNGEAL CARCINOMA.MOLECULAR MEDICINE. VOL. 17. ISSUE 3-4. P. 163 -171 | 21 | 36% | 10 |
7 | THOMADAKI, H , FLOROS, KV , SCORILAS, A , (2009) MOLECULAR RESPONSE OF HL-60 CELLS TO MITOTIC INHIBITORS VINCRISTINE AND TAXOL VISUALIZED WITH APOPTOSIS-RELATED GENE EXPRESSIONS, INCLUDING THE NEW MEMBER BCL2L12.NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS. VOL. 1171. ISSUE . P. 276-283 | 11 | 61% | 6 |
8 | THOMADAKI, H , FLOROS, KV , PAVLOVIC, S , TOSIC, N , GOURGIOTIS, D , COLOVIC, M , SCORILAS, A , (2012) OVEREXPRESSION OF THE NOVEL MEMBER OF THE BCL2 GENE FAMILY, BCL2L12, IS ASSOCIATED WITH THE DISEASE OUTCOME IN PATIENTS WITH ACUTE MYELOID LEUKEMIA.CLINICAL BIOCHEMISTRY. VOL. 45. ISSUE 16-17. P. 1362-1367 | 16 | 35% | 2 |
9 | FOUTADAKIS, S , AVGERIS, M , TOKAS, T , STRAVODIMOS, K , SCORILAS, A , (2014) INCREASED BCL2L12 EXPRESSION PREDICTS THE SHORT-TERM RELAPSE OF PATIENTS WITH TAT1 BLADDER CANCER FOLLOWING TRANSURETHRAL RESECTION OF BLADDER TUMORS.UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. VOL. 32. ISSUE 1. P. - | 12 | 43% | 0 |
10 | PAPAGEORGIOU, SG , KONTOS, CK , PAPPA, V , THOMADAKI, H , KONTSIOTI, F , DERVENOULAS, J , PAPAGEORGIOU, E , ECONOMOPOULOS, T , SCORILAS, A , (2011) THE NOVEL MEMBER OF THE BCL2 GENE FAMILY, BCL2L12, IS SUBSTANTIALLY ELEVATED IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS, SUPPORTING ITS VALUE AS A SIGNIFICANT BIOMARKER.ONCOLOGIST. VOL. 16. ISSUE 9. P. 1280-1291 | 17 | 28% | 6 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 36779 | CDK11P58//PITSLRE//CDK11 |
2 | 19375 | OBLIMERSEN//G3139//ANTISENSE BCL 2 |
3 | 640 | MCL 1//BCL 2 FAMILY//BH3 MIMETIC |
4 | 13947 | P53//AREA BIOPATOL//BCL 2 |
5 | 27700 | JOINT SERV BIOMARKER EVALUAT ONCOL//KI67 SCORE//LOCDIR |
6 | 28260 | CASP8 652 6N DEL//CASPASE8//CASP8 |
7 | 31081 | HEPATOMA DERIVED GROWTH FACTOR//HDGF//HEPATOMA DERIVED GROWTH FACTOR HDGF |
8 | 35523 | APOPTOTIC INDUCTION//IN VIVO ANTIFUNGAL ACTIVITIES//ARALIA CONTINENTALIS |
9 | 36462 | ZBP 89//ZNF148//BAK GENES |
10 | 15859 | TAXOL//PACLITAXEL//BCL 2 PHOSPHORYLATION |